Biomarkers for diagnosis of neonatal sepsis: a literature review

D Sharma, N Farahbakhsh, S Shastri… - The Journal of Maternal …, 2018 - Taylor & Francis
Sepsis is an important cause of mortality and morbidity in neonatal populations. There has
been constant search of an ideal sepsis biomarker that have high sensitivity, specificity …

Intraventricular hemorrhage in very preterm infants: a comprehensive review

V Gilard, A Tebani, S Bekri, S Marret - Journal of clinical medicine, 2020 - mdpi.com
Germinal matrix-intraventricular-intraparenchymal hemorrhage (GMH-IVH-IPH) is a major
complication of very preterm births before 32 weeks of gestation (WG). Despite progress in …

Metabolomics Application in Maternal‐Fetal Medicine

V Fanos, L Atzori, K Makarenko… - BioMed research …, 2013 - Wiley Online Library
Metabolomics in maternal‐fetal medicine is still an “embryonic” science. However, there is
already an increasing interest in metabolome of normal and complicated pregnancies, and …

NMR metabolomics of human blood and urine in disease research

IF Duarte, SO Diaz, AM Gil - Journal of Pharmaceutical and Biomedical …, 2014 - Elsevier
This paper reviews the main applications of NMR metabolomics of blood and urine in
disease research, over the last 5 years. The broad range of disease types addressed attests …

Oxidative stress and bronchopulmonary dysplasia: evidences from microbiomics, metabolomics, and proteomics

L Capasso, G Vento, C Loddo, C Tirone… - Frontiers in …, 2019 - frontiersin.org
Bronchopulmonary dysplasia is a major issue affecting morbidity and mortality of surviving
premature babies. Preterm newborns are particularly susceptible to oxidative stress and …

Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease

V Fanos, M Cristina Pintus, M Lussu… - The Journal of …, 2014 - Taylor & Francis
Objective: Bronchopulmonary dysplasia (BPD) or chronic lung disease is one of the
principal causes of mortality and morbidity in preterm infants. Early identification of infants at …

Metabolomics and the great obstetrical syndromes–GDM, PET, and IUGR

A Dessì, FC Marincola, V Fanos - … Practice & Research Clinical Obstetrics & …, 2015 - Elsevier
Gestational diabetes mellitus, intrauterine growth restriction, and preeclamptic toxemia are
common pregnancy complications that can have detrimental effects on morbidity and …

Metabolomics perspectives in pediatric research

S Moco, S Collino, S Rezzi, FPJ Martin - Pediatric research, 2013 - nature.com
Increasing evidence points toward the critical and long-term involvement of prenatal and
early nutrition and lifestyle on later health and disease risk predisposition. Metabolomics is …

Metabolomics in pharmacology-a delve into the novel field of pharmacometabolomics

M Mussap, C Loddo, C Fanni… - Expert review of clinical …, 2020 - Taylor & Francis
Introduction: Pharmacometabolomics is an emerging science pursuing the application of
precision medicine. Combining both genetic and environmental factors, the so-called …

Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology

M Mussap, A Noto, V Fanos… - BioMed research …, 2014 - Wiley Online Library
Identification of novel drug‐induced toxic nephropathy and acute kidney injury (AKI)
biomarkers has been designated as a top priority by the American Society of Nephrology …